Rare diseases
Investigational molecules
Locations
BI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
PolandA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
PolandA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
PolandA study to evaluate the effectiveness of barzolvolimab in participants with cold urticaria and symptomatic dermographism
PolandA study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
PolandA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
PolandA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
PolandA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
PolandA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
PolandA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
PolandStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
PolandA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
